Pediatric cancer research institute developing genomic and therapeutic breakthroughs
Children's Cancer Institute is Australia's independent medical research organization focused on childhood cancer, operating a genomic sequencing and drug-discovery pipeline with long-read platforms (Oxford Nanopore, PacBio), bioinformatics tools (Nextflow, Python, R), and CRISPR gene-editing capability. Active hiring across research, engineering, and marketing—with adoption of retrieval-augmented generation (RAG)—suggests expansion into AI-driven data synthesis alongside traditional laboratory workflows. Pain-point data reveals a dual operational focus: scientific (data integrity, legacy-system migration, health data harmonization) and supporter-facing (retention, conversion, journey automation), typical of research nonprofits scaling both discovery and fundraising.
Notable leadership hires: Head of Communications
Children's Cancer Institute conducts medical research into pediatric cancer diagnosis, treatment, and long-term survivorship outcomes. Based at UNSW Randwick, the organization operates research labs, genomic sequencing facilities, and translational-medicine programs aimed at advancing treatment protocols and reducing treatment-related complications. The institute employs 201–500 staff across research, engineering, clinical, and operations functions. Current work spans genomic workflows, nanotherapeutics development, and multi-site patient enrollment initiatives. The organization also manages supporter and donor engagement programs to fund research operations.
Oxford Nanopore and PacBio long-read platforms, integrated with Nextflow bioinformatics pipelines written in Python, Perl, and R.
Headquartered at UNSW Randwick, NSW, Australia. All hiring is currently in Australia.
Other companies in the same industry, closest in size